Use of Vitamin K Antagonists and Brain Volumetry in Older Adults: Preliminary Results From the GAIT Study

J Am Geriatr Soc. 2015 Oct;63(10):2199-202. doi: 10.1111/jgs.13682.

Authors

Cedric Annweiler^{1

2}, Soraya Denis³, Guillaume Duval¹, Guylaine Ferland⁴, Robert Bartha², Olivier Beauchet¹

Affiliations

¹ Department of Neuroscience, Division of Geriatric Medicine, Laboratoire de Psychologie des Pays de la Loire, L'Université Nantes Angers Le Mans, Angers University Hospital, Angers, France.
² Robarts Research Institute, Department of Medical Biophysics, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada.
³ School of Medicine, University of Angers, L'Université Nantes Angers Le Mans, Angers, France.
⁴ Centre de Recherche, Institut Universitaire de Gériatrie de Montréal, Montréal, Quebec, Canada.

PMID: 26480989
DOI: 10.1111/jgs.13682

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Antifibrinolytic Agents* / pharmacokinetics
Antifibrinolytic Agents* / therapeutic use
Atrophy / diagnosis
Atrophy / etiology
Biological Availability
Cognition Disorders* / diagnosis
Cognition Disorders* / etiology
Cognition Disorders* / metabolism
Female
Hippocampus / pathology*
Humans
Intelligence Tests
Magnetic Resonance Imaging / methods
Male
Neuroimaging / methods
Sphingolipids / metabolism
Statistics as Topic
Vitamin K Deficiency* / chemically induced
Vitamin K Deficiency* / complications
Vitamin K Deficiency* / metabolism
Vitamin K* / antagonists & inhibitors
Vitamin K* / metabolism

Substances

Antifibrinolytic Agents
Sphingolipids
Vitamin K